
What You Need to Know about Liquid Biopsy
Five years ago, the FDA approved the first liquid biopsy test for use in patients with cancer, providing cancer teams and patients a less invasive and more efficient way to detect disease. But liquid biopsies aren't cheap, and reimbursement for them can be unpredictable and confusing.
On this episode of CANCER BUZZ, learn about the current clinical applications of liquid biopsies, associated reimbursement issues, and what you can do to implement these tests at your program.
Guests:
J. Nicholas Bodor, MD, PhD, MPH, Assistant Professor, Department of Hematology/Oncology, Fox Chase Cancer Center…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.